Novel human coronavirus infection classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 2: | Line 2: | ||
{{Novel human coronavirus infection}} | {{Novel human coronavirus infection}} | ||
{{CMG}}; {{AE}} {{ADI}} | {{CMG}}; {{AE}} {{ADI}} | ||
==Classification== | ==Classification== | ||
Line 21: | Line 19: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[category:Needs overview]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:virology]] | [[Category:virology]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] |
Revision as of 01:18, 2 January 2013
Novel Human Coronavirus Infection Microchapters |
Differentiating Novel Human Coronavirus Infection from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Novel human coronavirus infection classification On the Web |
American Roentgen Ray Society Images of Novel human coronavirus infection classification |
Novel human coronavirus infection classification in the news |
Directions to Hospitals Treating Novel human coronavirus infection |
Risk calculators and risk factors for Novel human coronavirus infection classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]
Classification
- HCoV-229E
- HCoV-OC43
- SARS-CoV
- NL63/NL/New Haven coronavirus
- HKU1-CoV
- HCoV-EMC
- Novel Coronavirus 2012